Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9DXH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,280
Award facts
- Contract value 100% obligated
- $8,279.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,279.67 on January 28, 2026, for the supply of Xifaxan 550 mg tablets (60-count packages). The contract is non-competitively set aside and features firm fixed pricing with an ultimate completion date of January 29, 2026. The Defense Logistics Agency, which falls under the Department of Defense, is the funding federal agency. This delivery order represents a task order executed under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
The delivery order fulfills military healthcare supply needs for a specific antibiotic medication and demonstrates Amerisourcebergen's continued role as a critical vendor within the federal pharmaceutical supply chain. The company's contract portfolio with DLA encompasses a diverse range of therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The short performance timeline reflects the urgent nature of pharmaceutical delivery orders, typical of federal medical procurement to ensure continuity of supply for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9DXH?
SPE2DR26F9DXH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9DXH worth?
The government has obligated $8,280 on SPE2DR26F9DXH.
Is contract SPE2DR26F9DXH an order under another contract?
Yes. SPE2DR26F9DXH is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DXH competed?
The extent of competition for SPE2DR26F9DXH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award